|
KMID : 0355620210470060480
|
|
Journal of Korean Association of Oral and Maxillofacial Surgeons
2021 Volume.47 No. 6 p.480 ~ p.483
|
|
|
Autologous blood derived cell therapy in maxillofacial bone graft surgery
|
|
Park Joo-Young
|
|
|
Abstract
|
|
|
|
Tissue regeneration is one of the ultimate goals of maxillofacial surgery and various types of tissue engineering technologies have been utilized in clinics. Healthy resources of host cells and growth factors are essential for the tissue engineering, therefore autologous blood-derived cell therapy was introduced. In this article, clinical applications of the autologous platelet concentrates and stem cell separation therapy will be summarized and evaluated for their efficacy and feasibility in the current maxillofacial clinics.
|
|
|
KEYWORD
|
|
|
Tissue engineering, Regeneration, Maxilla, Mandible, Autografts
|
|
|
FullTexts / Linksout information
|
|
  
|
|
|
Listed journal information
|
|
 
|